These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29615501)

  • 61. CRISPR: development of a technology and its applications.
    Derry WB
    FEBS J; 2021 Jan; 288(2):358-359. PubMed ID: 33300275
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optimized paired-sgRNA/Cas9 cloning and expression cassette triggers high-efficiency multiplex genome editing in kiwifruit.
    Wang Z; Wang S; Li D; Zhang Q; Li L; Zhong C; Liu Y; Huang H
    Plant Biotechnol J; 2018 Aug; 16(8):1424-1433. PubMed ID: 29331077
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.
    Shen B; Brown KM; Lee TD; Sibley LD
    mBio; 2014 May; 5(3):e01114-14. PubMed ID: 24825012
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
    Naeem M; Majeed S; Hoque MZ; Ahmad I
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discordant influence of Blastomyces dermatitidis yeast-phase-specific gene BYS1 on morphogenesis and virulence.
    Krajaejun T; Wüthrich M; Gauthier GM; Warner TF; Sullivan TD; Klein BS
    Infect Immun; 2010 Jun; 78(6):2522-8. PubMed ID: 20368350
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons.
    Billon P; Bryant EE; Joseph SA; Nambiar TS; Hayward SB; Rothstein R; Ciccia A
    Mol Cell; 2017 Sep; 67(6):1068-1079.e4. PubMed ID: 28890334
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pea early-browning virus-mediated genome editing via the CRISPR/Cas9 system in Nicotiana benthamiana and Arabidopsis.
    Ali Z; Eid A; Ali S; Mahfouz MM
    Virus Res; 2018 Jan; 244():333-337. PubMed ID: 29051052
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
    Bai B; Myklebust JH; Wälchli S
    Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Conditional Control of CRISPR/Cas9 Function.
    Zhou W; Deiters A
    Angew Chem Int Ed Engl; 2016 Apr; 55(18):5394-9. PubMed ID: 26996256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of CRISPR/Cas9-Mediated Genome Engineering by a Type I Interferon-Induced Reduction in Guide RNA Expression.
    Machitani M; Sakurai F; Wakabayashi K; Nakatani K; Takayama K; Tachibana M; Mizuguchi H
    Biol Pharm Bull; 2017; 40(3):272-277. PubMed ID: 28250269
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fitness effects of CRISPR endonucleases in
    Langmüller AM; Champer J; Lapinska S; Xie L; Metzloff M; Champer SE; Liu J; Xu Y; Du J; Clark AG; Messer PW
    Elife; 2022 Sep; 11():. PubMed ID: 36135925
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Using new genetic tools to study the pathogenesis of Blastomyces dermatitidis.
    Brandhorst TT; Rooney PJ; Sullivan TD; Klein BS
    Trends Microbiol; 2002 Jan; 10(1):25-30. PubMed ID: 11755082
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cas9HF1 enhanced specificity in Ustilago maydis.
    Zuo W; Depotter JR; Doehlemann G
    Fungal Biol; 2020; 124(3-4):228-234. PubMed ID: 32220383
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
    Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
    Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of Various Nuclear Localization Signal-Fused Cas9 Proteins and
    Hu P; Zhao X; Zhang Q; Li W; Zu Y
    G3 (Bethesda); 2018 Mar; 8(3):823-831. PubMed ID: 29295818
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells.
    Voets O; Tielen F; Elstak E; Benschop J; Grimbergen M; Stallen J; Janssen R; van Marle A; Essrich C
    PLoS One; 2017; 12(8):e0182974. PubMed ID: 28800587
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CRISPR/Cas: A powerful tool for gene function study and crop improvement.
    Zhang D; Zhang Z; Unver T; Zhang B
    J Adv Res; 2021 Mar; 29():207-221. PubMed ID: 33842017
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.